Pharma Archives - Page 46 of 88 - Boston Life Sciences Times

Casma Therapeutics Secures $7.6 Million in MJFF Funding to Advance Parkinson’s Disease Program

March 10, 2026

NEJM Publishes Data Suggesting Zorevunersen May Modify Disease Course in Dravet Syndrome

March 5, 2026

Arsenal Medical Treats First Patient with ResQFoam Device for Life-Threatening Abdominal Bleeding

March 4, 2026

THIS WEEK'S STORIES

ZoomRx Study Finds Routine Pediatric Vaccine Visits May Be Changing After Federal Guidance Shift

March 12, 2026

Odyssey Therapeutics Appoints H. Martin Seidel, Ph.D., to Scientific Advisory Board

March 10, 2026

Newton Women’s Health Company Reports Study Showing Leva Device Improves Fecal Incontinence Symptoms

March 9, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Pharma

Study Suggests Daily Multivitamin May Slow Biological Aging

Parabilis Medicines Reports Early Clinical Data Showing Zolucatetide Reduces Polyp Burden in Familial Adenomatous Polyposis

Amylyx Pharmaceuticals Narrows Losses in 2025 as Phase 3 Avexitide Trial Nears Completion

KalVista Highlights Patient Satisfaction, Early Treatment Benefits for EKTERLY at Major Allergy Meetings

Merck Unveils Late-Breaking Phase 3 Data on Doravirine/Islatravir HIV Regimen at CROI 2026

Most Read

ZoomRx Study Finds Routine Pediatric Vaccine Visits May Be Changing After Federal Guidance Shift

Carna Health Expands Global Chronic Kidney Disease Screening Programs on World Kidney Day

Pretzel Therapeutics Presents Preclinical Data Supporting PX578 Development for POLG Disease

Insulet Reports Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes

EDITOR PICKS

Casma Therapeutics Secures $7.6 Million in MJFF Funding to Advance Parkinson’s Disease Program

NEJM Publishes Data Suggesting Zorevunersen May Modify Disease Course in Dravet Syndrome

Arsenal Medical Treats First Patient with ResQFoam Device for Life-Threatening Abdominal Bleeding

THIS WEEK'S STORIES

ZoomRx Study Finds Routine Pediatric Vaccine Visits May Be Changing After Federal Guidance Shift

Odyssey Therapeutics Appoints H. Martin Seidel, Ph.D., to Scientific Advisory Board

Newton Women’s Health Company Reports Study Showing Leva Device Improves Fecal Incontinence Symptoms

POPULAR CATEGORY

ABOUT US

FOLLOW US